Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by International Prognostic Scoring System, cytogenetic and genetic studies-Reference-Cited by-同舟云学术

Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by International Prognostic Scoring System, cytogenetic and genetic studies

Published:2007-12-20 Issue:3 Volume:22 Page:544-550
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Huang T-C,Ko B-S,Tang J-L,Hsu C,Chen C-Y,Tsay W,Huang S-Y,Yao M,Chen Y-C,Shen M-C,Wang C-H,Tien H-F

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/2405076.pdf

Reference41 articles.

1. Barrett J, Saunthararajah Y, Molldrem J . Myelodysplastic syndrome and aplastic anemia: distinct entities or diseases linked by a common pathophysiology? Semin Hematol 2000; 37: 15–29.

2. Nand S, Godwin JE . Hypoplastic myelodysplastic syndrome. Cancer 1988; 62: 958–964.

3. Chen B, Zhao WL, Jin J, Xue YQ, Cheng X, Chen XT et al. Clinical and cytogenetic features of 508 Chinese patients with myelodysplastic syndrome and comparison with those in Western countries. Leukemia 2005; 19: 767–775.

4. Lee JH, Lee JH, Shin YR, Lee JS, Kim WK, Chi HS et al. Application of different prognostic scoring systems and comparison of the FAB and WHO classifications in Korean patients with myelodysplastic syndrome. Leukemia 2003; 17: 305–313.

5. Greenberg PL . Apoptosis and its role in the myelodysplastic syndromes: implications for disease natural history and treatment. Leuk Res 1998; 22: 1123–1136.

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myelodysplastic Neoplasms (MDS): The Current and Future Treatment Landscape;Current Oncology;2024-04-03

2. Accuracy of Blast Enumeration in Bone Marrow by Cytomorphology, Flow Cytometry Immunophenotyping, and Immunohistochemistry Methods in Patients with Myelodysplastic Neoplasm and Acute Myeloid Leukemia;Istanbul Medical Journal;2023-08-01

3. Updates in Classification of Myelodysplastic Syndrome;The Cancer Journal;2023-05

4. Hypocellular myelodysplastic syndromes (h-MDS): from clinical description to immunological characterization in the Italian multi-center experience;Leukemia;2022-05-21

5. Low-Risk Myelodysplastic Syndrome Revisited: Morphological, Autoimmune, and Molecular Features as Predictors of Outcome in a Single Center Experience;Frontiers in Oncology;2022-03-22